PER 2.44% 8.0¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-110

  1. V8
    10,803 Posts.
    lightbulb Created with Sketch. 204
    Hi

    Just made a pilot buy this morning and doing some research.

    How was sarepta sp so high and whats so valuable about a drug for DMD.

    assuming the 1 in 5000 have the disease that only makes 1 400 000 possible patients/customers worldwide.

    Hardly seems a viable business.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $3.675K 45.89K

Buyers (Bids)

No. Vol. Price($)
1 343 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 10000 1
View Market Depth
Last trade - 14.33pm 09/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.